Method for improving expression level of botulinum toxin light chain
By constructing a recombinant expression system of the wild-type lysis tag NT11 and its mutant mut7 in Escherichia coli and combining it with the overexpression of the molecular chaperone htpG, the problem of efficient expression of botulinum toxin light chain in host bacteria was solved, realizing an efficient and simplified production process and high-activity expression.
Patent Information
- Application Number
- CN202511733628.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-24
- Publication Date
- 2026-03-24
AI Technical Summary
In existing technologies, type A botulinum toxin light chains are difficult to express efficiently in host bacteria, and the use of traditional lysis-promoting tags requires subsequent enzymatic digestion, which increases process costs and complexity.
Using the wild-type fusion tag NT11 and its mutants, such as mut7, a recombinant expression system was constructed in E. coli through genetic engineering. By combining the overexpression of the molecular chaperone htpG, the expression vector and fusion tag were optimized to achieve efficient expression without enzyme digestion.
The expression level of botulinum toxin light chain was increased to 647 mg/L, which is 20-43% higher than that of traditional methods, while maintaining high activity and simplifying the production process.